Suppr超能文献

髓样分化初级反应蛋白 88(MyD88):TLR/IL-1R 信号的核心枢纽。

Myeloid Differentiation Primary Response Protein 88 (MyD88): The Central Hub of TLR/IL-1R Signaling.

机构信息

Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.

Department of Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.

出版信息

J Med Chem. 2020 Nov 25;63(22):13316-13329. doi: 10.1021/acs.jmedchem.0c00884. Epub 2020 Sep 29.

Abstract

Myeloid differentiation primary response protein 88 (MyD88) is a ubiquitously expressed cytoplasmic adaptor protein that plays a central role in the Toll-like receptor (TLR) and interleukin-1 receptor (IL-1R) signaling pathways. TLR/IL-1R pathways regulate the proliferation and differentiation of cells involved in the innate and adaptive immunity. Although the general TLR/IL-1R activation cascade is well understood, the molecular mechanisms involving MyD88 have only begun to surface in the past decade. In this review, we explore MyD88 structural biology, the role of posttranslational modifications (PTMs), and the recent developments in MyD88 inhibitor discovery and use. We also highlight the potential application of MyD88-targeted therapies in human diseases.

摘要

髓样分化初级反应蛋白 88(MyD88)是一种广泛表达的细胞质衔接蛋白,在 Toll 样受体(TLR)和白介素-1 受体(IL-1R)信号通路中发挥核心作用。TLR/IL-1R 通路调节参与固有和适应性免疫的细胞的增殖和分化。尽管一般的 TLR/IL-1R 激活级联反应已经得到很好的理解,但涉及 MyD88 的分子机制在过去十年才开始显现。在这篇综述中,我们探讨了 MyD88 的结构生物学、翻译后修饰(PTMs)的作用,以及 MyD88 抑制剂发现和应用的最新进展。我们还强调了 MyD88 靶向治疗在人类疾病中的潜在应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验